Updates in Diagnosis, Treatment, and Management of Metastatic Uveal Melanoma - Episode 1

How Uveal Melanoma Differs from Cutaneous Melanoma

Sunandana Chandra, MD, MS, explains how uveal melanoma is different from cutaneous melanoma, including prevalence, molecular mutations, and survival prognosis after metastasis.

Now Viewing
EP. 1: How Uveal Melanoma Differs from Cutaneous Melanoma
EP. 2: Common Symptoms of Uveal Melanoma and the Typical Diagnostic Journey of the Patient
EP. 3: Historic and Current Treatment Options for mUM
EP. 4: Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM
EP. 5: Patient Eligibility and Logistical and Safety Considerations for Tebentafusp Treatment in mUM
EP. 6: An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources
EP. 7: Treatment Options for Patients with mUM Who Are Ineligible for Bispecific T-Cell Receptor Immunotherapy
EP. 8: Advice for Patients Living with Metastatic Uveal Melanoma